Journal
CLINICAL AND MOLECULAR HEPATOLOGY
Volume 21, Issue 4, Pages 344-348Publisher
KOREAN ASSOC STUDY LIVER
DOI: 10.3350/cmh.2015.21.4.344
Keywords
Drug eluting beads; Hepatocellular carcinoma; Transarterial chemoembolization
Categories
Funding
- 2-year Research Grant of Pusan National University
Ask authors/readers for more resources
Transarterial chemoembolization (TACE) using doxorubicin-eluting beads (DEBs) have been introduced as a novel device which ensures more sustained and tumor-selective drug delivery and permanent embolization compared to conventional TACE with lipiodol. Studies highlighting the use of TACE with DEBs for the treatment of hepatocellular carcinoma (HCC) have shown similar or better results compared to conventional TACE with lipiodol. TACE with DEBs is increasingly being performed interchangeably with conventional TACE. This review assessed the characteristics, clinical outcomes and future direction of TACE with DEBs compared to conventional TACE.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available